Synhale Therapeutics has acquired the rights to the experimental therapy telaglenastat (CB-839), which has previously been tested as a potential…
Articles by Marisa Wexler, MS
The PAH Initiative is hosting a video event in May to provide information about the benefits of exercise for…
The advocacy organization Phaware is launching a series of podcasts to explore new advances in the treatment of…
Treatment with the approved therapy Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people…
The U.S. Food and Drug Administration (FDA) is poised to soon issue a final determination on Yutrepia, an inhaled dry…
People with coarctation of aorta, or COA — a condition marked by narrowing where the body’s largest blood vessel connects…
Merck announced that its Phase 3 clinical trial HYPERION, which had been testing Winrevair (sotatercept-csrk) in people with…
An imaging technique called 18F-FAPI PET may be able to detect the earliest signs of changes in blood vessel tissues…
Using in-depth analyses and machine learning, scientists have identified several molecules and genes involved in metabolism that may be diagnostic…
Sildenafil is generally more effective than bosentan at controlling blood pressure and reducing the need for supplemental oxygen in infants…
High levels of a small RNA molecule in the blood may be a marker of pulmonary arterial hypertension (PAH)…
A Phase 2 clinical trial of TX45, Tectonic Therapeutic’s investigational therapy for pulmonary hypertension and heart failure…